EEG resting-state gamma power as a potential biomarker of excitation / inhibition imbalance in autism: Evidence from the Autism Biomarkers Consortium for Clinical Trials.
Identification of neural biomarkers is one of the central challenges in autism research as they could significantly advance our understanding of the brain mechanisms of symptom trajectories, serve as objective markers in clinical trials (e.g., for subgrouping children, or use for prognostic relationship), and lead to t...